Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Issues in GERD
- Definition of GERD
- Los Angeles classification
- Get your definitions right
- NERD is important
- Prevalence of GERD (1)
- Prevalence of GERD (2)
- Symptom relief after 4 weeks in NERD patients
- Predictors of NERD vs. ERD
- NERD is not homogenous
- 24-hr pH study
- Is most NERD MERD?
- Mechanisms of symptom production in NERD
- Sub classification of NERD
- Functional heartburn (1)
- Predictors of functional heartburn vs. pH + NERD
- Development of symptoms in GERD patients
- Laparoscopic fundoplication
- Functional heartburn (2)
- Role of DGER in "resistant" GERD
- NERD: management issues
- What are the limits of GERD?
- Heartburn and quality of life (1)
- Heartburn and quality of life (2)
- GERD in China (1)
- GERD in China (2)
- Symptom severity and quality of life
- Natural history
- Progression in ProGERD (1)
- Progression in ProGERD (2)
- Determination of GERD
- Extra-esophageal, supra-esophageal GERD
- Laryngitis
- Non-acid reflux
- Cough and GERD
- Meta-analysis of primary outcome
- Meta-analysis of cough scores
- Cochrane
- Non-traditional reflux and cough
- Asthma
- PPI and asthma (1)
- PPI and asthma (2)
- Scleroderma and GERD
- The Barrett's dilemma
- How do we proceed?
- Risk factors for Barrett's and adenocarcinoma
- Can we predict progression?
- Genetics
- Screen followed by surveillance?
- Prague criteria
- Barrett's management issues
- GERD management issues
- Summary - approaches to the patients with GERD
- Issues in choosing a PPI
- Key points
Topics Covered
- What is GERD
- NERD non-erosive reflux disease
- Predictors of NERD vs. ERD
- Mechanisms of symptom production in NERD
- Functional heartburn
- Predictors of functional heartburn vs. pH + NERD
- Factors leading to the development of symptoms in GERD patients
- Role of DGER in "resistant" GERD
- NERD: management issues
- The limits of GERD
- Progression in ProGERD
- Extra-esophageal, supra-esophageal GERD
- Laryngitis
- Cough and GERD
- Asthma and GERD
- Scleroderma and GERD
- The Barrett's dilemma
- Risk factors for Barrett's and adenocarcinoma
- Genetic markers that can predict progression
- Barrett's management issues
- GERD management issues
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Quigley, E.M.M. (2011, February 15). The spectrum of GERD implications for assessment and management [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/ABUY2588.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Eamonn M. M. Quigley, Consultant: Alimentary Health, Allergen, Commonwealth Laboratories, Rhythm, Salix, Synergy, Vibrant Speaker’s Bureau: Procter and Gamble Grant/Research Support (Principal Investigator): Rhythm, Therevance, Vibrant Stock Shareholder (Self-managed): Alimentary Health